Targeted Tablet Approved for ESR1 Breast Cancer

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/targeted-tablet-approved-esr1-breast-cancer-2026a10005xy?src=rss

Author :

Publish date : 2026-02-25 14:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Targeted Tablet Approved for ESR1 Breast Cancer

Trump Touched on Healthcare in State of the Union Speech: Here’s What He Said

Cream Cheese Recall; Nobel Winner Resigns Over Epstein Ties; Cadaver Fat in Surgery

Related Posts

Treating Asthma in Pregnancy: What Clinicians Should Know

Human Metapneumovirus Is Not the Next COVID

‘People with ADHD are great in a crisis’

Medicare Coverage Appears Spotty for Newer Rheumatoid Arthritis Meds

Patients harmed as Covid pandemic brought NHS close to collapse, inquiry finds

Closing the Vaccination Gap for Adults With Chronic Conditions

Treating Asthma in Pregnancy: What Clinicians Should Know

Human Metapneumovirus Is Not the Next COVID

‘People with ADHD are great in a crisis’

Medicare Coverage Appears Spotty for Newer Rheumatoid Arthritis Meds

Patients harmed as Covid pandemic brought NHS close to collapse, inquiry finds

Closing the Vaccination Gap for Adults With Chronic Conditions

Why Is Extreme Heat a Mental Health Emergency?

Supplement-Tied Outbreak Hospitalizes 26; Kid Vax Rates Plummet; TrumpRx Discounts?

Categories

Archives